Invention Grant
- Patent Title: Methods and systems for predicting response to immunotherapies for treatment of cancer
-
Application No.: US15376276Application Date: 2016-12-12
-
Publication No.: US10969392B2Publication Date: 2021-04-06
- Inventor: Justin M. Balko , Douglas B. Johnson , Violeta Sanchez de Delgado , Melinda Sanders
- Applicant: Vanderbilt University
- Applicant Address: US TN Nashville
- Assignee: Vanderbilt University
- Current Assignee: Vanderbilt University
- Current Assignee Address: US TN Nashville
- Agency: Stites & Harbison PLLC
- Agent Summer E. Young; Mandy Wilson Decker
- Main IPC: A61K39/395
- IPC: A61K39/395 ; G01N33/574 ; A61K31/416 ; C07K16/28 ; A61K38/45 ; A61K31/166 ; A61K31/44 ; A61K31/4523 ; A61K31/519 ; A61K31/4412 ; G01N33/569 ; A61K39/00

Abstract:
A method of detecting cell membrane expression of an MHC molecule in a subject, a method of treating cancer in a subject with an immunotherapeutic agent, and an MHC complex are provided. The method of detecting cell membrane expression of an MHC molecule includes obtaining a tumor cell sample from a subject, and detecting cell membrane expression of the MHC molecule by contacting the tumor cell sample with an antibody targeting the MHC molecule and detecting binding between the MHC molecule and the antibody. The method of treating cancer in a subject with an immunotherapeutic agent includes detecting cell membrane expression of an MHC molecule in the subject and administering a therapeutically effective amount of the immunotherapeutic agent if the level of cell membrane expression of the MHC molecule exceeds a predetermined standard. The complex includes a tumor cell in complex with an antibody or an antigen-binding portion thereof.
Public/Granted literature
- US20170168054A1 Methods and Systems for Predicting Response to Immunotherapies for Treatment of Cancer Public/Granted day:2017-06-15
Information query